Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-23

Clinical Trial Update: Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development

View source ↗

Summary

A completed investigation evaluating whether the MMP-2 gene polymorphism rs243865 is associated with susceptibility to cataract development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sohag University | Conditions: Cataract | Status: COMPLETED